Certain compounds are able to decrease the specific uptake of oestradiol in vivo and in vitro by various target tissues of the rat (Terenius & Ljungkvist, 1972; Geynet et al., 1972; Skidmore et al., 1972) and man Hahnel etal., 1973; Lunan & Green, 1974) . These substances, some steroids and synthetic anti-oestrogens, are able to inhibit the selective transfer of oestrogens by specific receptor macromolecules to the chromatin of target tissues (Jensen et al., 1971; , 1973 , and have been found useful in distinguishing between the interactions of oestradiol with specific and non-specific binding proteins . Such anti-oestrogens have an important therapeutic role in the treatment of women with advanced carcinoma of the breast (Terenius, 1971 in the text) . In some experiments, free and nonspecifically bound steroid were removed from the cytosol by treatment with dextran-coated charcoal (0.5 % Norit-A, 0.05% dextran T-70, sedimented from I ml of medium A).
Linear 5 ml (5-20%, w/v) sucrose density gradients in a uniform concentration of medium A were prepared as described by Martin & Ames (1961) .
Samples of 3H-labelled cytosol (400pu1) were layered over the gradients and centrifuged at lOOOOOgav. for 18h at 3-40C. One gradient in each set was layered with bovine serum albumin (s20,w 4.6S; 4mg in 400,ul) as a sedimentation marker. Gradients were fractionated by upward displacement by sucrose (>40Y%, w/v) and three-drop fractions collected and analysed as described by Davies & Griffiths (1973) .
Results and Discussion
Analysis of 3H-labelled cytosol preparations from rat mammary tumours showed two peaks of proteinbound radioactivity corresponding to [3H]oestradiolreceptor complexes of approximate sedimentation coefficients 4S and 8S (Fig. la) . The low capacity of the 8S peak was demonstrated by the displacement of radioactivity to the high-capacity 4S peak by the presence of a 100-fold excess of unlabelled oestradiol (Fig. la) . Whereas a similar concentration (5OnM) of either diethylstilboestrol or dibutyldihydrostilboestrol produced an identical displacement (Fig. lb) , diethylstilboestrol, but not dibutyldihydrostilboestrol, caused some depression of the 8S peak at a concentration of 5nM (Fig. 2) . I.C.I. 46474 abolished the 8S peak at a concentration of 50nM (Fig. lc) and caused a significant depression at 5nM (Fig. 2b) . I.C.I. 79792 (50nM) was not as effective as I.C.I. 46474 at the same concentration ( Fig. Ic) and had no effect at 5nM (Fig. 2b) . The other nitrogen-mustard-containing compound, I.C.I. 85966, generally failed to diminish [3H]oestradiol binding to the 8S receptor (Fig. la) , although it should be noted that in two of the rat mammary-tumour cytosols studied (Fig. Id) Cytosol prepared from samples of human breast carcinoma and labelled with [3H]oestradiol (0.5nM) also showed two peaks of radioactivity when analysed by sucrose-density-gradient centrifugation. Removal with charcoal of free and loosely bound steroid indicated, however, high-affinity binding in both the 4S and 8S peaks (Fig. 2c) , as previously reported (McGuire & DeLaGarza, 1973) . Preliminary studies showed that this specific binding could be decreased by a 50nM concentration of either diethylstilboestrol, dibutyldihydrostilboestrol and I.C.I. 46474 (Fig. 2c) , but only diethylstilboestrol was successful at 5nM (Fig. 2d) .
Diethylstilboestrol and I.C.I. 46474, therefore, were the two most active anti-oestrogens studied, whereas dibutyldihydrostilboestrol and I.C.I. 79792 were quite effective at higher concentrations. Dibutyldihydrostilboestrol may, however, prove useful in the clinical management of breast cancer, since it displays only 1 % of the oestrogenicity of diethylstilboestrol (Grundy, 1957) . This latter compound was more efficient than I.C.I. 46474 in displacing [3H]oestradiol from human breast-carcinoma receptor proteins, whereas the converse was true for rat mammary-carcinoma receptor proteins; this may be due to a species variation in the protein. However, I.C.I. 46474 has been used clinically in the management of breast cancer (Cole et al., 1971; Ward, 1973) .
The binding of oestradiol to receptor proteins has been postulated to occur by the initial attachment of the C-3 phenolic hydroxyl group to a highly specific site facilitating the attraction of the C-17 f,-hydroxyl function to a less specific binding site (Hahnel & Twaddle, 1974) . It is obvious that diethylstilboestrol and dibutyldihydrostilboestrol could also bind through the two phenolic hydroxyl groupings. The nitrogen-mustard derivative of diethylstilboestrol, I.C.I. 85966, may lose its ability to compete with [3H]oestradiol because ofthe dichloroethylcarbamoyl grouping. It is possible that its occasional effect (Fig. ld) may be due to some metabolic process resulting in the loss of these groups. It has been suggested, however, that the inhibition of specific [3H]oestradiol binding of I.C.I. 46474 is due to allosteric competition (Hahnel et al., 1973) . This would be brought about by the association of the aromatic N-ethyl ether grouping to a site on the receptor protein other than that specific for oestradiol. Whether the inhibition is of a simple competitive or allosteric type, replacement of the NN-dimethyl group by the NN-(2-chloroethyl) group to produce I.C.I. 79792 may decrease the affinity at this site and may account for the lower anti-oestrogenic properties of this compound. 
